About six months after the launch of Ayushman Bharat – Narendra Modi Government’s ambitious health plan – At least 17,000 health and wellness centres (HWCs) have started working across the country, apart from non-communicable diseases (NCD) Services are being provided for. Services for fertility and child health, communicable diseases etc.
This was stated by Union Health Secretary Preeti Sudan, in a program organized here, where the World Health Organization (WHO) officials along with the Union Health Ministry signed a solid human chain as part of the World Health Day celebrations on April 7. Formation, so that their commitment can be re-confirmed, reducing the gap between universal health coverage (UHC) Additive manner to work.
Sudan said, “The government is committed to strengthening 150,000 health facilities in the form of HWC, which will provide comprehensive primary health care for the people in rural and urban areas.” The topic of World Health Day 2019 is UHC: Everyone, everywhere.
In fact, India is already working to achieve this goal through its National Health Policy 2017, whose goal is to fully combine with the concept of UHC so that AYUSH intervention (Traditional systems of medicine such as Ayurveda) can be supported. NCD is like diabetes, which is strengthening its deadly grip on more and more Indians. One study said that about 9.8 million people in India could have type 2 diabetes by 2030.
As part of the government’s universal health-related strategy, scientifically made herbal drugs such as BGR-34 are made of herbal medicines such as Barahindra, Gilloy, Gudmar and Kareli, for their anti-diabetic and anti-hyperglycemic agents. Is known. Diabetic patients are treated as remedial and preventive health strategies.
The anti-diabetic drug was developed jointly by two laboratories based at the Scientific and Industrial Research Council (CSIR) of Lucknow-Central Institute of Medicinal and Aromatic Plants (CIMAP) and National Institute of Botany, after standardization and pre-clinical studies. has gone. NBRI). It is being marketed by Delhi-based AIMIL Pharmaceuticals from 2016.
It is used only by the diagnosis of diabetes patients as a means of managing the disease; AYUSH Union Minister Shripad Naik also said in the Rajya Sabha last year.
A senior official of AYUSH said that in three years out of four lakh patients registered in hospitals in Rajasthan, Gujarat, Bihar and Chhattisgarh for diabetes, high blood pressure and high cholesterol, three lakh people reduced the AYUSH interventions.
He said that all three lakh patients were seen to improve somewhat and their dependence on medication decreased.
Excited by the response, the AYUSH Ministry has now proposed AYUSH interventions in 12 health services, which include pregnancy and childbirth, neonatal and infant care, family planning and contraception, general external patient care and opiate and ENT problems.
